No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Body Burden
-
Female
-
Humans
-
Male
-
Metabolic Clearance Rate
-
Middle Aged
-
Neuroendocrine Tumors / diagnostic imaging
-
Neuroendocrine Tumors / metabolism*
-
Neuroendocrine Tumors / radiotherapy
-
Octreotide / analogs & derivatives*
-
Octreotide / pharmacokinetics*
-
Octreotide / therapeutic use
-
Organ Specificity
-
Radiation Injuries / prevention & control
-
Radiation Protection / methods
-
Radiometry / methods*
-
Radionuclide Imaging
-
Radiopharmaceuticals / pharmacokinetics
-
Radiopharmaceuticals / therapeutic use
-
Radiotherapy Dosage
-
Radiotherapy Planning, Computer-Assisted / methods*
-
Relative Biological Effectiveness
-
Risk Assessment / methods*
-
Risk Factors
-
Somatostatin / analogs & derivatives*
-
Somatostatin / pharmacokinetics
-
Somatostatin / therapeutic use
-
Tissue Distribution
-
Yttrium Radioisotopes / pharmacokinetics*
-
Yttrium Radioisotopes / therapeutic use
Substances
-
Radiopharmaceuticals
-
Yttrium Radioisotopes
-
Somatostatin
-
pentetreotide
-
Octreotide